Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)
Conditions: Migraine; Migraine Disorders; Migraine With Aura; Headache Disorders Interventions: Drug: Patients with migraine treated with triptans, Lasmiditan or Gepants Sponsors: Hospital Cl ínico Universitario de Valladolid Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
SENSE-VM: Safety and Effectiveness of a Novel Medical Device for Symptom Ease in Vestibular Migraines
Conditions: Vestibular Migraine; Migraine Associated Vertigo Interventions: Device: Otoband Experimental; Device: Otoband Sham Sponsors: Otolith Labs; MCRA Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants, TRI-DI-GEP: an International Prospective Multicentric Cohort Study
Conditions: Migraine; Migraine Disorders; Migraine With Aura; Headache Disorders Interventions: Drug: Patients with migraine treated with triptans, Lasmiditan or Gepants Sponsors: Hospital Cl ínico Universitario de Valladolid Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
Influence of Dalcroze Eurhythmics on Pains in Older Women
Conditions: Back Pain; Headache; Leg Pain Interventions: Other: Physical exercise program Sponsors: Poznan University of Physical Education Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Magnesium and Riboflavin Treatment for Post-Concussion Headache
Conditions: Concussion, Intermediate Interventions: Drug: magnesium and riboflavin supplement Sponsors: University of Virginia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Continuous combined oral contraceptive use versus vitamin E in the treatment of menstrual migraine: rationale and protocol of a randomized controlled trial (WHAT!)
ConclusionsThe WHAT! trial aims to investigate effectivity and safety of continuous combined oral contraceptive treatment for menstrual migraine. Immediate implementation of results in clinical practice is possible.Trial registrationClinical trials.govNCT04007874. Registered 28 June 2019. (Source: Trials)
Source: Trials - February 15, 2024 Category: Research Source Type: clinical trials
Pathophysiological Mechanisms and Implication of Treatment in Postural Puncture Headache
Conditions: Post-Dural Puncture Headache Interventions: Other: MRI examination Sponsors: Ume å University; Region Västerbotten Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Conditions: Episodic Migraine Interventions: Drug: Atorvastatin 40mg; Drug: Placebo; Drug: Atorvastatin 20mg Sponsors: St. Olavs Hospital; Haukeland University Hospital; Oslo University Hospital; University Hospital of North Norway; University Hospital, Akershus; Ullevaal University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Valproate Versus Topiramate in Migraine
Conditions: Migraine Disorders Interventions: Drug: Valproic acid; Drug: Topiramate 50 MG Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
Pulse Radiofrequency and Occipital Nerve Block for Chronic Migraine Patients
Conditions: Chronic Migraine, Headache; Block; Occipital Neuralgia Interventions: Procedure: Greater occipital nerve block; Procedure: Greater occipital nerve pulse radiofrequency Sponsors: Aydin Adnan Menderes University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
An Acute Migraine Factorial Study
Conditions: Migraine With or Without Aura Interventions: Drug: Naltrexone and Acetaminophen; Drug: Naltrexone and Acetaminophen-High Dose; Drug: Naltrexone Alone (regular dose); Drug: Acetaminophen Alone; Drug: Matching Placebo Sponsors: Allodynic Therapeutics, Inc Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2024 Category: Research Source Type: clinical trials
Lacosamide Versus Topiramate in Migraine
Conditions: Migraine Disorders Interventions: Drug: Lacosamide 50 MG; Drug: Topiramate 50Mg Tab Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab
Conditions: Migraine Disorders; Migraine With Aura; Migraine Without Aura; Brain Diseases Interventions: Drug: Fremanezumab Prefilled Syringe Sponsors: Hospital Cl ínico Universitario de Valladolid; University of Valladolid; Complejo Asistencial Universitario de Palencia; Complejo Público Asistencial de Zamora Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Comparison of Occipital Nerve and Sphenopalatine Ganglion Blockade
Conditions: Migraine Interventions: Procedure: greater occipital nerve block; Procedure: transnasal sphenopalatine ganglion block Sponsors: Ankara University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2024 Category: Research Source Type: clinical trials
Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity in Adult Participants With Migraine
Conditions: Migraine Interventions: Drug: Atogepant; Drug: Placebo for Atogepant Sponsors: AbbVie Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 5, 2024 Category: Research Source Type: clinical trials
